Supplementary Figure S2 from SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST)

2026 Open access

Read full text Summarise with VIRAT
Authors: AeRang Kim, Karla V. Ballman, Pamela L. Wolters, Rachel S. Heise, Jack F. Shern, R. Taylor Sundby, Liza Lindenberg, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Shirin Shahsavari, Angela C. Hirbe
+12 more Brian Andrew Van Tine, Christian F. Meyer, Christine A. Pratilas, Natalie Bucheimer Collins, Geraldine O’Sullivan Coyne, Alice P. Chen, Eva Dombi, Roshan L. Shrestha, Andrea M. Gross, Denise K. Reinke, Karen M. Cichowski, Brigitte C. Widemann
DOI: 10.1158/1078-0432.31744839
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Effects of combination therapy of NK receptors and co-receptors

Fields of Study & Subjects

Neurofibromatosis and Schwannoma Cases Sarcoma Diagnosis and Treatment Neuroblastoma Research and Treatments

Publication details

Publication date
16 March 2026
Language
EN